In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
After finishing at $13.48 in the prior trading day, Arcutis Biotherapeutics Inc (NASDAQ: ARQT) closed at $13.27, down -1.56%. In other words, the price has decreased by -$1.56 from its previous closing price. On the day, 1.31 million shares were traded.
Ratios:
Our goal is to gain a better understanding of ARQT by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.37 and its Current Ratio is at 3.55. In the meantime, Its Debt-to-Equity ratio is 0.78 whereas as Long-Term Debt/Eq ratio is at 0.77.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on December 30, 2024, initiated with a Buy rating and assigned the stock a target price of $19.
On August 28, 2024, Jefferies started tracking the stock assigning a Buy rating and target price of $15.
Mizuho Upgraded its Neutral to Buy on January 03, 2024, whereas the target price for the stock was revised from $4 to $8.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 28 ’25 when Matsuda Masaru sold 1,800 shares for $13.78 per share. The transaction valued at 24,807 led to the insider holds 202,599 shares of the business.
Matsuda Masaru bought 1,800 shares of ARQT for $24,807 on May 28 ’25. On May 21 ’25, another insider, Heron Patrick J, who serves as the Director of the company, bought 2,520 shares for $13.66 each. As a result, the insider paid 34,423 and bolstered with 20,014 shares of the company.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 7.43 while its Price-to-Book (P/B) ratio in mrq is 11.08.
Stock Price History:
Over the past 52 weeks, ARQT has reached a high of $17.75, while it has fallen to a 52-week low of $6.99. The 50-Day Moving Average of the stock is -7.60%, while the 200-Day Moving Average is calculated to be 6.87%.
Shares Statistics:
A total of 119.14M shares are outstanding, with a floating share count of 104.83M. Insiders hold about 12.05% of the company’s shares, while institutions hold 98.78% stake in the company.
